Opthea Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Ocular Therapeutix Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology. | |
Founding Date | Founding Date 2012 | Founding Date 1996 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations South Yarra, AU HQ Toorak, AU | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Bedford, US HQ Bedford, US Bedford, US |
Employees | Employees 33 | Employees 75,883 | Employees 16740% increase |
Valuation ($) | Valuation ($) 711.2 m | Valuation ($) N/A | Valuation ($) 1.8 b |
Financial | |||
Revenue (est.) | Revenue (est.) $25k (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $52m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $8.4b (FY, 2025) | Cost of goods $6.6m (FY, 2025) |
Gross profit | Gross profit $146k (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $45.4m (FY, 2025) |
Net income | Net income ($162.8m) (FY, 2025) | Net income $14b (FY, 2025) | Net income ($265.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 67.6m | Total funding raised $ 6.5m | Total funding raised $ 73.3m |

Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
View company